$EBC

Eastern Bankshares (NASDAQ: EBC) director plans new stock sale

Eastern Bankshares (EBC) director Joseph F. Casey plans to sell 1,778 shares, valued at $40,342, under Rule 144. He sold 10,000 shares each on four dates in August 2026, totaling $921,800. EBC has 228,511,552 shares outstanding.

Original reporting
Published Aug 25, 2026, 4:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 5:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EBC
Neutral
high confidence
Mentioned
$EBC
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$EBCNeutralLow
01

Why it matters

The disclosed sale adds a modest amount of supply to the market, but the scale is trivial.

02

Market read

Insider sale filing with minimal market impact; primarily of interest to shareholders and compliance monitors.

03

What to watch

Potential cumulative effect if multiple insiders sell in a short period.

Relevance 4/10Novelty 4/10Timing: today (08/25/2026)

Background

Form 144 filing by a director indicates upcoming public sale of restricted shares.

Company-level read

Ticker impact

$EBCNeutralHigh confidence
Context

Director Joseph F. Casey filed a Rule 144 notice to sell 1,778 shares of Eastern Bankshares, valued at $40,342.82.

Expected impact

Minimal downward pressure, likely negligible impact on share price.

Evidence & confidence

The sale size is small relative to total shares outstanding (228.5M) and represents less than 0.001% of float.

Market effects

No material effect on the regional banking sector.

Limited to Eastern Bankshares investors; broader market unchanged.

None

Counterpoint

Even small insider sales can signal lack of confidence; watch for further disposals.

Key entities

  • Eastern Bankshares, Inc.

    U.S. regional bank listed on NASDAQ.

  • Joseph F. Casey

    Director of Eastern Bankshares filing the Rule 144 notice.

Related articles

$EBCMed

Eastern Bankshares, Inc. Reports Second Quarter 2026 Financial Results

Eastern Bankshares, Inc. (EBC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 ebc-20260630xq22026earning.htm EX-99.1 Q2 2026 EARNINGS RELEASE Document Exhibit 99.1 Eastern Bankshares, Inc. Reports Second Quarter 2026 Financial Results Company Announces 5% Repurchase Authorization • Net income of $ 105.2 million, or $0.48 per diluted share, included

$RAREHighAI 9/10

Ultragenyx agrees to sell voucher for US$210M

Ultragenyx Pharmaceutical (NASDAQ: RARE) agreed to sell a rare pediatric disease priority review voucher for $210M, nearly half its cash reserves. The deal, subject to regulatory approval, follows the FDA's August approval of its Genglycos gene therapy. Shares rose 2.97% on the news. Ultragenyx plans to use proceeds to advance rare disease therapies and support profitability. The price is within the range of recent voucher transactions, such as Rocket Pharmaceuticals' $180M deal.

$SLBMed

How New Energy Contracts Will Impact SLB (SLB) Stock

SLB (SLB) secured multi-year energy contracts with Aramco and ExxonMobil, expanding its backlog in onshore and deepwater infrastructure. Analysts project $43.0b revenue and $5.5b earnings by 2029, with potential upside. The company's focus on digital and data center solutions is seen as a driver for higher revenue.

$CEGMed

Big Tech Keeps Signing Nuclear Deals With the Same Company. Here's Who It Is and Why That Matters More Than Any Single Deal.

Constellation Energy (CEG) signed a deal with Alphabet's Google to supply 890 MW of nuclear power, highlighting its role in powering AI growth for tech giants. CEG operates outside regulated utilities, offering direct power sales to companies like Microsoft, Meta, and Amazon. Its scale, diverse energy portfolio, and long-term contracts support growth, though its stock remains 25% below 2025 highs.

$LCIDMed

Lucid Builds Fewer EVs Than It Sells As CEO’s Cash-Preservation Reset Takes Hold

Lucid Group reported Q3 production of 2,954 EVs and deliveries of 3,806, down from last year. The company is reducing inventory and aligning output with demand under CEO Silvio Napoli's operational reset. Lucid aims to improve cash flow by $1.4B in 2026. Analysts expect a Q3 loss of $2.30 per share and revenue of $570.42M. The stock has a Hold consensus rating with an average price target of $10.20.